Author

Jungjoong Hwang

Observed institutions: Ministry of Food and Drug Safety, Hallym University, Kangwon National University, National Institute of Food and Drug Safety Evaluation

OpenAlex ID: A5089852879

Identification of a new tadalafil analogue in an adulterated dietary supplement: Trans-Bisprehomotadalafil

2015 · Ji Hyun Lee, Ji Hyun Lee, et al. · Journal of Pharmaceutical and Biomedical Analysis · 16

Stereoselective Protection-Free Asymmetric Total Synthesis of (+)-Chamuvarinin, a Potent Anticancer and Antitrypanosomal Agent: Substrate-Controlled Construction of the Adjacently Linked Oxatricyclic Core by Internal Alkylation

2018 · Mallesham Samala, Thien Nhan Lu, et al. · Organic Letters · 13

Synthesis and Structure Revision of Dimeric Tadalafil Analogue Adulterants in Dietary Supplements

2017 · Suresh Mandava, Bogonda Ganganna, et al. · Chemical and Pharmaceutical Bulletin · 10

Metabolic and pharmacokinetic characterization of a new synthetic cannabinoid APINAC in rats

2017 · Jungjoong Hwang, Jiho Hwang, et al. · Forensic Toxicology · 8

Highly Stereoselective Asymmetric Total Synthesis of (−)-Jimenezin via Sequential Intramolecular Amide Enolate Alkylation

2022 · Thien Nhan Lu, Minjung Kwak, et al. · Organic Letters · 7

Cross-Metathesis of Methallyl Halides: Concise Enantioselective Formal Total Synthesis of (–)-Presphaerene

2020 · Suresh Mandava, Jaun Koo, et al. · Frontiers in Chemistry · 3

KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth

2020 · Jungjoong Hwang, Insuk Song, et al. · Investigational New Drugs · 2

Evaluation of the therapeutic potential of nucerin, an oral TGR5 agonist HY209, in a murine model of alzheimer’s disease

2024 · Siwon Kim, Jahirul Islam, et al. · Alzheimer s & Dementia · 1

A Review on the 2016 US FDA Botanical Drug Development Guideline Based on Approvals of Veregen and Fulyzaq

2018 · Insuk Song, Jungjoong Hwang, et al. · Yakhak Hoeji · 1

First Syntheses of (±)‐Butesuperins A and B

2017 · Bogonda Ganganna, Thien Nhan Lu, et al. · Bulletin of the Korean Chemical Society · 1

A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis

2025 · Gyeong Ho Baek, Bo Ri Kim, et al. · Frontiers in Immunology

Works count: 11

Citation count: 62

H-index: 5

I10-index: 3